Helus Pharma share price logo

Helus Pharma

NASDAQ: HELP

Small Cap

$11.60

-0.16

(-1.36%)

as on

Helus Pharma Stock Performance

as on September 2, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $11.50
    $12.16
    downward going graph

    0.86%

    Downside

    4.83%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Helus Pharma share price movements today

Previous Close
$11.76
Open
$11.76
Volume
921.8K
Market Cap
$859.2M
Day's Low - High
$11.50 - $12.16

Helus Pharma Historical Returns

1 Month Return
+ 48.34 %
3 Month Return
+ 154.95 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Helus Pharma Stock Fundamentals & Key Indicators

Check Helus Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$859.2M

EPS (TTM)

-5.51

Dividend Yield

0.00%

PE Ratio (TTM)

-3.33

Industry PE ratio

-6.724375

PEG Ratio

-0.1489106132637768

Return On Equity TTM

-74.47%

Helus Pharma Stock Valuation

Track how Helus Pharma P/E has moved over time to understand its valuation trends.

Helus Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-36.99x)

March 31, 2023

Industry (-6.72x)

March 31, 2026

Today (-1.13x)

March 31, 2026

Highest (-1.13x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: -1.13x

Helus Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Helus Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$859.2MNA-3.330.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Analyst Recommendation on Helus Pharma Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Helus Pharma. Average target price of $35.33

Indian Investors' Interest in Helus Pharma Stock

Search interest for Helus Pharma Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:67% versus previous 30 day period

Helus Pharma Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
0
Operating Income
-27
-25
-14
-57
-32
-24
-40
-41
-47
-47
EBITDA
-26
-25
-14
-57
-32
-24
-40
-41
-47
-47
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-30
-21
-10
-56
-10
-24
-47
-42
-46
-46
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-30
-21
-10
-56
-10
-24
-47
-42
-46
-46
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Helus Pharma Annual Profit & Loss

All numbers in Millions USD

Jul 2017
Jul 2018
Jul 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Jun 2025
Mar 2026
Total Revenue
-
-
-
-
0
0
0
-
0
-44
Gross Profit
-
-
-
-
0
-
-
-
-
-44
Operating Income
0
0
0
-1
-31
-63
-51
-78
-143
-141
EBITDA
0
0
0
0
-30
-63
-51
-78
-142
-141
Interest Expense
-
-
-
-
0
-
-
-
-
-
Depreciation
-
-
-
1
0
0
0
0
0
0
Income Before Tax
0
0
0
-1
-32
-67
-47
-78
-113
-57
Income Tax Expense
-
-
-
-
-
0
0
-
0
89
Net Income
0
0
0
-1
-32
-67
-47
-78
-113
-147
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
23.15%
0.00%
0.00%
0.00%
0.00%
100.27%

Helus Pharma Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-30
-21
-10
-56
-10
-18
-47
-42
-46
-46
Operating Cash Flow
-26
-20
-19
-25
-26
-21
-48
-31
-36
-36
Investing Cash Flow
7
0
0
0
0
0
0
0
0
0
Financing Cash Flow
39
190
0
0
0
40
0
143
0
45
Change in Cash
20
169
-20
-26
-28
18
-48
111
-36
8

Helus Pharma Annual Cash Flow

All numbers in Millions USD

Jul 2017
Jul 2018
Jul 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Jun 2025
Mar 2026
Net Income
0
0
0
0
-32
-67
-47
-78
-113
-147
Operating Cash Flow
0
0
0
0
-19
-45
-47
-68
-101
-132
Investing Cash Flow
0
0
0
0
-1
0
-3
6
-1
-1
Financing Cash Flow
0
0
-
0
82
35
13
254
20
196
Change in Cash
0
0
0
0
62
-10
-37
192
-73
63

Global Institutional Holdings in Helus Pharma

Funds
Holdings
AdvisorShares
0.5%
Chuck Royce
0.32%
Invesco
0.03%
Kenneth Tropin
0.03%
T. Rowe Price
0%

Helus Pharma News & Key Events

  • img

    Today's Timeline - 25 June

    Thu, 08:34 PM

    -

    Helus Pharma closes US$50 million offering of 10,309,280 common shares at US$4.85 each to fund mental health drug development.

Insights on Helus Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, HELP stock has moved up by 154.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 537.7% return, outperforming this stock by 451.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 37.1% return, outperforming this stock by 38.9%

About Helus Pharma

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company' preclinical product includes HLP005, a phenethylamine and tryptamine derivative to treat central nervous system. It has a strategic partnership agreement with Segal Trials to evaluating HLP003 for the adjunctive treatment of major depressive disorder; and with Osmind for mental health treatments. The company is headquartered in Toronto, Canada.
OrganisationHelus Pharma
Headquarters100 King Street West, Toronto, ON, Canada, M5X 1C9
IndustryBiotechnology
CEOMr. Michael I. Halstead J.D.
E-voting on sharesClick here to vote

Key Management of Helus Pharma

Name

Title

Mr. Eric So L.L.B.

Co-Founder, President & Executive Chairman

Mr. Greg Cavers

Chief Financial Officer

Mr. Michael I. Halstead J.D.

Chief Executive Officer

Sara Brittany Somerset

Chief Communications Officers

Dr. Geoff Varty Ph.D.

Senior Vice President of Research & Pre-Clinical Development

FAQs

What is Helus Pharma share price today?

Helus Pharma share price today is $11.60 as on at the close of the market. Helus Pharma share today touched a day high of $12.16 and a low of $11.50.

What is the 52 week high and 52 week low for Helus Pharma share?

Helus Pharma share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Helus Pharma stock price today i.e. is closed at $11.60,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Helus Pharma's market capitalisation today?

Helus Pharma market capitalisation is $0.00T as on .

How to invest in Helus Pharma Stock (HELP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Helus Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Helus Pharma Shares that will get you 0.1293 shares as per Helus Pharma share price of $11.60 per share as on September 2, 2026 at 8:45 am IST.

What is the minimum amount required to buy Helus Pharma Stock (HELP) from India?

Indian investors can start investing in Helus Pharma (HELP) shares with as little as ₹94.96 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Helus Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Helus Pharma share’s latest price of $11.60 as on September 2, 2026 at 8:45 am IST, you will get 0.8621 shares of Helus Pharma. Learn more about fractional shares .